147 related articles for article (PubMed ID: 30552423)
1. A National French consensus on gene lists for the diagnosis of myopathies using next-generation sequencing.
Krahn M; Biancalana V; Cerino M; Perrin A; Michel-Calemard L; Nectoux J; Leturcq F; Bouchet-Séraphin C; Acquaviva-Bourdain C; Campana-Salort E; Molon A; Urtizberea JA; Audic F; Chabrol B; Pouget J; Froissart R; Melki J; Rendu J; Petit F; Métay C; Seta N; Sternberg D; Fauré J; Cossée M
Eur J Hum Genet; 2019 Mar; 27(3):349-352. PubMed ID: 30552423
[TBL] [Abstract][Full Text] [Related]
2. [Towards a national standardisation of NGS studies in the diagnosis of myopathies].
Krahn M; Cerino M; Campana-Salort E; Cossée M
Med Sci (Paris); 2017 Nov; 33 Hors série n°1():30-33. PubMed ID: 29139383
[No Abstract] [Full Text] [Related]
3. Best practice guidelines for the use of next-generation sequencing applications in genome diagnostics: a national collaborative study of Dutch genome diagnostic laboratories.
Weiss MM; Van der Zwaag B; Jongbloed JD; Vogel MJ; Brüggenwirth HT; Lekanne Deprez RH; Mook O; Ruivenkamp CA; van Slegtenhorst MA; van den Wijngaard A; Waisfisz Q; Nelen MR; van der Stoep N
Hum Mutat; 2013 Oct; 34(10):1313-21. PubMed ID: 23776008
[TBL] [Abstract][Full Text] [Related]
4. Genetic testing offer for inherited neuromuscular diseases within the EURO-NMD reference network: A European survey study.
Peterlin B; Gualandi F; Maver A; Servidei S; van der Maarel SM; Lamy F; Mejat A; Evangelista T; Ferlini A
PLoS One; 2020; 15(9):e0239329. PubMed ID: 32946487
[TBL] [Abstract][Full Text] [Related]
5. Targeted gene panel use in 2249 neuromuscular patients: the Australasian referral center experience.
Beecroft SJ; Yau KS; Allcock RJN; Mina K; Gooding R; Faiz F; Atkinson VJ; Wise C; Sivadorai P; Trajanoski D; Kresoje N; Ong R; Duff RM; Cabrera-Serrano M; Nowak KJ; Pachter N; Ravenscroft G; Lamont PJ; Davis MR; Laing NG
Ann Clin Transl Neurol; 2020 Mar; 7(3):353-362. PubMed ID: 32153140
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations.
Pujol P; Vande Perre P; Faivre L; Sanlaville D; Corsini C; Baertschi B; Anahory M; Vaur D; Olschwang S; Soufir N; Bastide N; Amar S; Vintraud M; Ingster O; Richard S; Le Coz P; Spano JP; Caron O; Hammel P; Luporsi E; Toledano A; Rebillard X; Cambon-Thomsen A; Putois O; Rey JM; Hervé C; Zorn C; Baudry K; Galibert V; Gligorov J; Azria D; Bressac-de Paillerets B; Burnichon N; Spielmann M; Zarca D; Coupier I; Cussenot O; Gimenez-Roqueplo AP; Giraud S; Lapointe AS; Niccoli P; Raingeard I; Le Bidan M; Frebourg T; Rafii A; Geneviève D
Eur J Hum Genet; 2018 Dec; 26(12):1732-1742. PubMed ID: 30089825
[TBL] [Abstract][Full Text] [Related]
7. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
[TBL] [Abstract][Full Text] [Related]
8. Repeat genetic testing with targeted capture sequencing in primary arrhythmia syndrome and cardiomyopathy.
Robyns T; Kuiperi C; Breckpot J; Devriendt K; Souche E; Van Cleemput J; Willems R; Nuyens D; Matthijs G; Corveleyn A
Eur J Hum Genet; 2017 Dec; 25(12):1313-1323. PubMed ID: 29255176
[TBL] [Abstract][Full Text] [Related]
9. Next-Generation Sequencing to Diagnose Muscular Dystrophy, Rhabdomyolysis, and HyperCKemia.
Wu L; Brady L; Shoffner J; Tarnopolsky MA
Can J Neurol Sci; 2018 May; 45(3):262-268. PubMed ID: 29382405
[TBL] [Abstract][Full Text] [Related]
10. [Discussion on the standard of clinical genetic testing report and the consensus of gene testing industry].
Huang H; Shen Y; Gu W; Wang W; Wang Y; Qi M; Shen J; Qiu Z; Yu S; Zhou Z; Chen B; Chen L; Chen Y; Cui H; Du J; Gao Y; Guo Y; Hu C; Hu L; Huang Y; Li P; Li X; Li X; Liu Y; Lu J; Ma D; Ma Y; Peng M; Song F; Sun H; Wang L; Wang D; Wang J; Wang L; Wang Z; Wang Z; Wu J; Wu J; Wu J; Xu Y; Yao H; Yang D; Yang X; Yang Y; Zhang Y; Zhou Y; Zhu B; Zeng S; Peng Z; Huang S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Feb; 35(1):1-8. PubMed ID: 29419850
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive genomic approach for neuromuscular diseases gives a high diagnostic yield.
Ankala A; da Silva C; Gualandi F; Ferlini A; Bean LJ; Collins C; Tanner AK; Hegde MR
Ann Neurol; 2015 Feb; 77(2):206-14. PubMed ID: 25380242
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for genetic testing of muscle and neuromuscular junction disorders.
Nicolau S; Milone M; Liewluck T
Muscle Nerve; 2021 Sep; 64(3):255-269. PubMed ID: 34133031
[TBL] [Abstract][Full Text] [Related]
13. Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study.
Marino P; Touzani R; Perrier L; Rouleau E; Kossi DS; Zhaomin Z; Charrier N; Goardon N; Preudhomme C; Durand-Zaleski I; Borget I; Baffert S;
Eur J Hum Genet; 2018 Mar; 26(3):314-323. PubMed ID: 29367707
[TBL] [Abstract][Full Text] [Related]
14. Early-Onset Myopathies: Clinical Findings, Prevalence of Subgroups and Diagnostic Approach in a Single Neuromuscular Referral Center in Germany.
Vill K; Blaschek A; Gläser D; Kuhn M; Haack T; Alhaddad B; Wagner M; Kovacs-Nagy R; Tacke M; Gerstl L; Schroeder AS; Borggraefe I; Mueller C; Schlotter-Weigel B; Schoser B; Walter MC; Müller-Felber W
J Neuromuscul Dis; 2017; 4(4):315-325. PubMed ID: 29172004
[TBL] [Abstract][Full Text] [Related]
15. The utility of genetic testing in neuromuscular disease: A consensus statement from the AANEM on the clinical utility of genetic testing in diagnosis of neuromuscular disease.
Kassardjian CD; Amato AA; Boon AJ; Childers MK; Klein CJ;
Muscle Nerve; 2016 Dec; 54(6):1007-1009. PubMed ID: 27554703
[TBL] [Abstract][Full Text] [Related]
16. NGS panel analysis in 24 ectopia lentis patients; a clinically relevant test with a high diagnostic yield.
Overwater E; Floor K; van Beek D; de Boer K; van Dijk T; Hilhorst-Hofstee Y; Hoogeboom AJM; van Kaam KJ; van de Kamp JM; Kempers M; Krapels IPC; Kroes HY; Loeys B; Salemink S; Stumpel CTRM; Verhoeven VJM; Wijnands-van den Berg E; Cobben JM; van Tintelen JP; Weiss MM; Houweling AC; Maugeri A
Eur J Med Genet; 2017 Sep; 60(9):465-473. PubMed ID: 28642162
[TBL] [Abstract][Full Text] [Related]
17. [A consensus on the standardization of the next generation sequencing process for the diagnosis of genetic diseases (2) - Sample collection, processing and detection].
Zeng X; Xu Z; Huang H; Qu W; Wu J; Wang J; Gao Y; An D; Wang X; Xiong H; Shen Y; Qi M; Deng X; Xu X; Sun L; Peng Z; Gu W; Huang S; Yu S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Mar; 37(3):339-344. PubMed ID: 32128755
[TBL] [Abstract][Full Text] [Related]
18. Clinical validation of targeted next-generation sequencing for inherited disorders.
Yohe S; Hauge A; Bunjer K; Kemmer T; Bower M; Schomaker M; Onsongo G; Wilson J; Erdmann J; Zhou Y; Deshpande A; Spears MD; Beckman K; Silverstein KA; Thyagarajan B
Arch Pathol Lab Med; 2015 Feb; 139(2):204-10. PubMed ID: 25611102
[TBL] [Abstract][Full Text] [Related]
19. Is it research or is it clinical? Revisiting an old frontier through the lens of next-generation sequencing technologies.
Bertier G; Cambon-Thomsen A; Joly Y
Eur J Med Genet; 2018 Oct; 61(10):634-641. PubMed ID: 29704685
[TBL] [Abstract][Full Text] [Related]
20. National recommendations of the French Genetics and Cancer Group - Unicancer on the modalities of multi-genes panel analyses in hereditary predispositions to tumors of the digestive tract.
Dhooge M; Baert-Desurmont S; Corsini C; Caron O; Andrieu N; Berthet P; Bonadona V; Cohen-Haguenauer O; De Pauw A; Delnatte C; Dussart S; Lasset C; Leroux D; Maugard C; Moretta-Serra J; Popovici C; Buecher B; Colas C; Noguès C;
Eur J Med Genet; 2020 Dec; 63(12):104080. PubMed ID: 33039684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
